We found 1 episode of Oncology Today with Dr Neil Love with the tag “sars-cov2”.
-
Dr Jeff Sharman Comments on the Use of BTK Inhibitors as Treatment for Patients with SARS-CoV-2
June 5th, 2020 | 27 mins 40 secs
cancer, cancer treatment, chemotherapy, chronic lymphocytic leukemia, cll, covid, covid-19, dr neil love, hematology, oncology, oncology education, research to practice, sars-cov2
Dr Jeff Sharman from the Willamette Valley Cancer Institute and Research Center discusses clinical trials evaluating the use of Bruton tyrosine kinase inhibitors as treatment for patients with SARS-CoV-2.